1. Clinical toxicity of antiretroviral nucleoside analogs;Styrt;Antiv Res,1996
2. Farmacologia Integrada;Page,1999
3. Biopharmaceutics Classification System (BCS);International Pharmaceutical Federation (FIP),2009
4. Proposal to waive in vivo bioequivalence requirements for WHO Model List of Essential Medicines immediate-release, solid oral dosage forms;WHO,2006
5. Guidances for industry: Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a Biopharmaceutics Classification System;U.S., Department of Health and Human Services, Food and Drug Administration, Center for Evaluation and Research (CDER),2000